AstraZeneca says its antibody drug Evusheld can fight Omicron
AstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetails
AstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetails
The fresh Indo-US trade deal announced by US President Donald Trump 2 February will see American tariffs on Indian goods...
Read moreDetails
China’s President Xi Jinping now finds himself in an enviable position enjoying kind of a special superpower status as countries,...
Read moreDetails
For an economy plagued by multiple ailments – a daily depreciating currency, growing household debt, high unemployment and inequality, exodus...
Read moreDetails
By Aakar Patel As a democratic society, it is expected that India’s authorities follow the rule of law. This includes...
Read moreDetails